Provectus Biopharmaceuticals, Inc. (PVCT) bonds
PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$0.05+0.00 (+0.39%)
Close on Oct 19, 2026Market cap $20.55MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Provectus Biopharmaceuticals reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Provectus Biopharmaceuticals's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Amount issued | Carrying value |
|---|---|---|---|
| Two Thousand Twenty Five Convertible Notes Payable Convertible | 8.00% | – | $3.31M |
| Two Thousand Twenty Five Financing Note | 8.00% | $3.21M | – |
| Two Thousand Twenty Four Convertible Notes Payable Convertible | 8.00% | – | – |
| Two Thousand Twenty One Convertible Notes Payable Convertible | – | – | $163.44K |
| Two Thousand Twenty One Note | 8.00% | $100.00K | – |
| Two Thousand Twenty Two Note | 8.00% | – | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?